Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023

Dana E. Moseson, Tran Trong Bien, Bharathi Karunakaran, Rohan Ambardekar, Tze Ning Hiew
ISSN / E-ISSN
— / —
DOI
10.1016/j.ijpx.2024.100259 ↗
Volume · Issue · Pages
7 · — · 100259-100259
Publisher
Elsevier BV
Article URL
https://doi.org/10.1016/j.ijpx.2024.100259 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Jun 2024
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Jun 2024 OpenAlex

Keywords (as given): amorphous solid dispersions; copovidone; hypromellose acetate succinate; spray drying; melt extrusion; tablets; fixed-dose combination; pediatric dosing; pharmaceutical excipients; film coating; antiviral agents; anticancer agents

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2023–24.
Journal
International Journal of Pharmaceutics: X
Publication date used
01 Jun 2024 (OpenAlex publication date)
Applicable HEC period
2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
Category
X
Recognition status
Recognized (OK_RECORD_FOUND)
Source
HJRS 2023-24 page 1638, row 11592
Verification status
Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.